Quest Diagnostics (DGX) Gross Profit: 2009-2024
Historic Gross Profit for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $3.2 billion.
- Quest Diagnostics' Gross Profit rose 17.02% to $949.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 15.73%. This contributed to the annual value of $3.2 billion for FY2024, which is 6.26% up from last year.
- Per Quest Diagnostics' latest filing, its Gross Profit stood at $3.2 billion for FY2024, which was up 6.26% from $3.1 billion recorded in FY2023.
- Quest Diagnostics' 5-year Gross Profit high stood at $4.2 billion for FY2021, and its period low was $3.1 billion during FY2023.
- For the 3-year period, Quest Diagnostics' Gross Profit averaged around $3.2 billion, with its median value being $3.2 billion (2024).
- In the last 5 years, Quest Diagnostics' Gross Profit spiked by 35.11% in 2020 and then declined by 18.44% in 2022.
- Over the past 5 years, Quest Diagnostics' Gross Profit (Yearly) stood at $3.6 billion in 2020, then climbed by 15.85% to $4.2 billion in 2021, then dropped by 18.44% to $3.4 billion in 2022, then fell by 11.07% to $3.1 billion in 2023, then grew by 6.26% to $3.2 billion in 2024.